Bicara Therapeutics (BCAX) Selling, General & Administrative Expenses

Annual SGA

$9.27 M
+$2.93 M+46.15%

December 31, 2023

Summary

Performance

1-Year Change

+46.15%

3-Year Change

+46.15%

5-Year Change

+46.15%

15-Year Change

+46.15%

BCAX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.61%
BCAX annual SGA is higher than 20.61% of companies in Healthcare sector

High & Low

All-time High

$9.27 M
BCAX annual SGA is currently at an all-time high

3-Year Low

$6.34 M
BCAX annual SGA is currently +46.15% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BCAX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
BCAX next annual earnings announcement is scheduled for Feb 28, 2025

OtherBCAXexpensesmetrics:

Annual Total Expenses

$39.89 M
BCAX annual total expenses is $39.89 million

Annual Operating Expenses

$39.89 M
BCAX annual total operating expenses is $39.89 million

Annual Cost Of Goods Sold

-
BCAX annual cost of goods sold value is unknown

Annual Interest Expense

$0.00
BCAX annual interest expense is $0.00

Quarterly SGA

$4.76 M
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

BCAX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.7%
BCAX quarterly SGA is higher than 36.7% of companies in Healthcare sector

High & Low

All-time High

$4.76 M
BCAX quarterly SGA is currently at an all-time high

3-Year Low

$2.59 M
BCAX quarterly SGA is currently +83.87% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCAX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
BCAX next earnings announcement is scheduled for Feb 28, 2025

OtherBCAXexpensesmetrics:

Quarterly Total Expenses

$20.63 M
BCAX quarterly total expenses is $20.63 million

Quarterly Operating Expenses

$20.63 M
BCAX quarterly total operating expenses is $20.63 million

Quarterly Cost Of Goods Sold

-
BCAX quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
BCAX quarterly interest expense value is unknown

TTM SGA

-$535.66 M
-$200.06 M-59.61%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

BCAX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.83%
BCAX TTM SGA is higher than 60.83% of companies in Healthcare sector

High & Low

All-time High

-$153.02 M

3-Year Low

-$535.66 M
BCAX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCAX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
BCAX next earnings announcement is scheduled for Feb 28, 2025

OtherBCAXexpensesmetrics:

Annual Total Expenses

$39.89 M
BCAX annual total expenses is $39.89 million

Annual Operating Expenses

$39.89 M
BCAX annual total operating expenses is $39.89 million

TTM Cost Of Goods Sold

-
BCAX TTM cost of goods sold value is unknown

TTM Interest Expense

-
BCAX TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$9.27 M
BCAX annual SGA is $9.27 million

Annual Operating Expenses

$39.89 M
BCAX annual total operating expenses is $39.89 million

Annual Cost Of Goods Sold

-
BCAX annual cost of goods sold value is unknown

BCAX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.1%--
3 y3 years+46.1%--
5 y5 years+46.1%--

BCAX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+46.1%at high+83.9%-250.1%at low
5 y5-yearat high+46.1%at high+83.9%-250.1%at low
alltimeall timeat high+46.1%at high+83.9%-250.1%at low

Bicara Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.76 M(+83.9%)
$4.76 M(+83.9%)
Dec 2023
$9.27 M
-
-
DateAnnualQuarterlyTTM
Sep 2023
-
$2.59 M
$2.59 M
Dec 2022
$6.34 M
-
-

FAQ

  • What is Bicara Therapeutics annual SGA?
  • What is the all time high annual SGA for Bicara Therapeutics?
  • What is Bicara Therapeutics annual SGA year-on-year change?
  • What is Bicara Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Bicara Therapeutics?
  • What is Bicara Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Bicara Therapeutics?

What is Bicara Therapeutics annual SGA?

The current annual SGA of BCAX is $9.27 M

What is the all time high annual SGA for Bicara Therapeutics?

Bicara Therapeutics all-time high annual SGA is $9.27 M

What is Bicara Therapeutics annual SGA year-on-year change?

Over the past year, BCAX annual SGA has changed by +$2.93 M (+46.15%)

What is Bicara Therapeutics quarterly SGA?

The current quarterly SGA of BCAX is $4.76 M

What is the all time high quarterly SGA for Bicara Therapeutics?

Bicara Therapeutics all-time high quarterly SGA is $4.76 M

What is Bicara Therapeutics TTM SGA?

The current TTM SGA of BCAX is -$535.66 M

What is the all time high TTM SGA for Bicara Therapeutics?

Bicara Therapeutics all-time high TTM SGA is -$153.02 M